{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02884",
      "entity_text" : "GMPc",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:145068",
      "entity_text" : "nitric oxide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Several pathophysiological pathways seem to be involved : prostaglandin pathway, acting on AMPc generation that can be fostered by the administration of prostacycline analogues [epoprostenol, treprostinil, iloprost, beraprost]; nitric oxide pathway, enhancing the production of GMPc, which is inhibited by phosphodiesterase-V that can be blocked by its inhibitors [sidenafil, tadalafil]; and the endothelin-1 pathway, acting as a potent endothelial vasoconstrictor that can be partially blocked by endothelin receptor antagonists [bosentan, ambrisentan, sitaxentan] [XREF_BIBR].",
  "reading_complete" : "2020-08-03T12:23:16Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:17:21Z",
  "trigger" : "enhancing",
  "evidence" : [ "nitric oxide pathway, enhancing the production of GMPc" ],
  "pmc_id" : "2682922",
  "score" : 0
}